Hong Kong: Scientists from Hong Kong have developed a groundbreaking solution for cancer treatment— CAR-T injection.
In November 2024, five cancer patients received this injection, and researchers have reported that they are gradually recovering.
Promising Results with Global Demand Expected
The results of this treatment have been highly encouraging, and experts believe that CAR-T injection could see massive global demand in the future.
Additionally, scientists have confirmed that no adverse side effects were observed in patients who received the injection.
CAR-T Injection Trial Details
In October 2024, the Chinese University of Hong Kong conducted a clinical trial on five cancer patients aged between 5 and 73 years.
By February 2025, these five patients had shown significant recovery from cancer.
They are now healthy, and their experiences have been documented for further research.
Cost of CAR-T Injection
Currently, this treatment is not available for the general public.
The cost of CAR-T injection in Hong Kong is estimated to be around ₹3 crore (30 million INR), while in other countries, it is expected to be even more expensive.
Post-Treatment Care and Side Effects
- After receiving the CAR-T injection, patients need to be monitored in the ICU for seven days.
- Some side effects may occur, requiring specialized medical care to manage them.
- Currently, research indicates that CAR-T therapy is effective only for liver and lung cancer.
CAR-T Therapy in India
In 2023, IIT Bombay introduced CAR-T therapy in India under the NexCAR-19 project, making this advanced treatment available for Indian patients.
The Indian government, under the “Made in India” initiative, is working towards making cancer treatment more affordable.
According to the prestigious Nature Magazine, CAR-T therapy has already shown significant success in treating blood cancer in India.
With continuous advancements, CAR-T therapy could revolutionize cancer treatment worldwide, bringing hope to millions of patients.